The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter. detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.
November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device technology news for treating atrial fibrillation (AF or Afib) from the past six months.
New Technologies to Improve Atrial Fibrillation Ablation
Boston Scientific to Acquire EP Technology Company Apama Medical
VIDEO: Current State of Atrial Fibrillation Ablation Technologies - Interview with Hugh Calkins, M.D.
Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations
Mixed Results in PREVAIL Trial Comparing Five-Year Data for LAA Closure Compared to Warfarin
First Smartphone Compatible Insertable Cardiac Monitor Cleared by FDA
Wearable Cardiac Monitors Are Effective for Tracking Atrial Fibrillation Following Ablation
Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Cryoballoon Ablation Reduces Costs and Resource Utilization
Multi-Electrode RF Balloon Efficient for Acute Pulmonary Vein Isolation
What is New in Electrophysiology Technologies
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
CardioFocus Gains European CE Mark for HeartLight Excalibur Laser Ablation Balloon
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
Expert Consensus Released on Catheter, Surgical Ablation of Atrial Fibrillation
Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR
Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion
Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
VIDEO: Demonstration of the AcQMap High-resolution EP Mapping System
Stroke History Higher in Asymptomatic Versus Symptomatic Atrial Fibrillation Patients
Positive European Registry Results For Watchman Left Atrial Appendage Closure Device
Closure of Left Atrial Appendage During Heart Surgery Protects the Brain
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
Newer Anticoagulant Reduces Major Bleeds in AF Ablation
Most Atrial Fibrillation Patients Do Not Get Preventive Drug Before Stroke
October 30, 2024 
